RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 95 filers reported holding RA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,026,000 | +148.4% | 45,823 | +101.9% | 0.06% | +125.9% |
Q4 2018 | $413,000 | +14.1% | 22,698 | -66.8% | 0.03% | +80.0% |
Q1 2018 | $362,000 | +7.7% | 68,294 | +72.6% | 0.02% | 0.0% |
Q4 2017 | $336,000 | +78.7% | 39,570 | +292.9% | 0.02% | +50.0% |
Q2 2017 | $188,000 | – | 10,070 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |